HYBRIGENICS (Germany) Performance
| 3HB Stock | EUR 0.01 0.0002 2.82% |
The company owns a Beta (Systematic Risk) of 1.05, which attests to a somewhat significant risk relative to the market. HYBRIGENICS returns are very sensitive to returns on the market. As the market goes up or down, HYBRIGENICS is expected to follow. At this point, HYBRIGENICS A has a negative expected return of -0.072%. Please make sure to check out HYBRIGENICS's mean deviation, standard deviation, information ratio, as well as the relationship between the coefficient of variation and variance , to decide if HYBRIGENICS A performance from the past will be repeated at future time.
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
Over the last 90 days HYBRIGENICS A has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of rather sound fundamental drivers, HYBRIGENICS is not utilizing all of its potentials. The newest stock price tumult, may contribute to shorter-term losses for the shareholders. ...more
HYBRIGENICS |
HYBRIGENICS Relative Risk vs. Return Landscape
If you would invest 0.85 in HYBRIGENICS A on September 17, 2024 and sell it today you would lose (0.12) from holding HYBRIGENICS A or give up 14.12% of portfolio value over 90 days. HYBRIGENICS A is producing return of less than zero assuming 5.7463% volatility of returns over the 90 days investment horizon. Simply put, 51% of all stocks have less volatile historical return distribution than HYBRIGENICS, and 99% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
HYBRIGENICS Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for HYBRIGENICS's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as HYBRIGENICS A , and traders can use it to determine the average amount a HYBRIGENICS's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = -0.0125
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns | 3HB |
Estimated Market Risk
| 5.75 actual daily | 51 51% of assets are less volatile |
Expected Return
| -0.07 actual daily | 0 Most of other assets have higher returns |
Risk-Adjusted Return
| -0.01 actual daily | 0 Most of other assets perform better |
Based on monthly moving average HYBRIGENICS is not performing at its full potential. However, if added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of HYBRIGENICS by adding HYBRIGENICS to a well-diversified portfolio.
HYBRIGENICS Fundamentals Growth
HYBRIGENICS Stock prices reflect investors' perceptions of the future prospects and financial health of HYBRIGENICS, and HYBRIGENICS fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on HYBRIGENICS Stock performance.
| Current Valuation | 21.57 M | |||
| Price To Book | 1.80 X | |||
| Price To Sales | 305,067 X | |||
| Total Asset | 13.15 M | |||
About HYBRIGENICS Performance
By analyzing HYBRIGENICS's fundamental ratios, stakeholders can gain valuable insights into HYBRIGENICS's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if HYBRIGENICS has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if HYBRIGENICS has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Things to note about HYBRIGENICS A performance evaluation
Checking the ongoing alerts about HYBRIGENICS for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for HYBRIGENICS A help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| HYBRIGENICS A generated a negative expected return over the last 90 days | |
| HYBRIGENICS A has high historical volatility and very poor performance | |
| HYBRIGENICS A has some characteristics of a very speculative penny stock |
- Analyzing HYBRIGENICS's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether HYBRIGENICS's stock is overvalued or undervalued compared to its peers.
- Examining HYBRIGENICS's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating HYBRIGENICS's management team can have a significant impact on its success or failure. Reviewing the track record and experience of HYBRIGENICS's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of HYBRIGENICS's stock. These opinions can provide insight into HYBRIGENICS's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for HYBRIGENICS Stock analysis
When running HYBRIGENICS's price analysis, check to measure HYBRIGENICS's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy HYBRIGENICS is operating at the current time. Most of HYBRIGENICS's value examination focuses on studying past and present price action to predict the probability of HYBRIGENICS's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move HYBRIGENICS's price. Additionally, you may evaluate how the addition of HYBRIGENICS to your portfolios can decrease your overall portfolio volatility.
| Investing Opportunities Build portfolios using our predefined set of ideas and optimize them against your investing preferences | |
| Portfolio Optimization Compute new portfolio that will generate highest expected return given your specified tolerance for risk |